AstraZeneca in the UK

The Discovery Centre (DISC) is a state-of-the-art research and development (R&D) facility located in the heart of the Cambridge Biomedical Campus. It is one of our three global R&D Centres and is designed to change the way scientists innovate and collaborate to help us accelerate the discovery and development of medicines across our key disease areas. It represents our belief in what science can do. The ground-breaking research undertaken at The DISC will enhance our understanding of disease biology, help us to discover novel ways to target drivers of disease, better predict clinical success, and pioneer new approaches to engagement in the clinic.
 

Employing approximately 2,900 people, including some of the world’s most skilled and experienced science professionals, Alderley Park is renowned for the discovery and development of innovative new medicines. As the lead centre for cancer research, Alderley Park currently houses the global Advanced Lead Discovery Centre, which includes innovative facilities to assist with the drug discovery process, in addition to oncology discovery and early development capabilities (Oncology Innovative Medicines). Alderley Park is also home to employees within our global medicines development function, who are responsible for the late stage development of our pipeline (products in phase III development). 
 

AstraZeneca’s UK Marketing Company (UKMC) is a part of our global commercial organisation, and is responsible for the marketing of our medicines in the UK. The UKMC’s base at Horizon Place is also home to colleagues from AstraZeneca’s corporate functions and our European and international regions’ sales and marketing teams (the latter includes markets in Latin America, the Middle East & Africa, Asia, and Australasia).
 

Macclesfield, in the north-west of England, is our second largest manufacturing site and our European centre for packing. Some 1,800 people are employed at our Macclesfield site, where we manufacture, pack and distribute our medicines to 130 global markets. Effective manufacturing processes are vitally important to our work, so we’ve introduced new techniques at Macclesfield which have increased efficiency significantly.
 

At Speke, near Liverpool, our biologics team plays a vital role in the UK's child flu vaccination programme, developing new vaccines each year to combat fresh strains and mutations.